Skip to main content

Table 2 Treatment and outcomes of the 35 patients

From: Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study

  Total (n = 35) With HCQ/CQ (n = 14) Without HCQ/CQ (n = 21) P value
Treatment
 Antivirus agents     
  Ribavirin 9 4 5 1.000
  Lopinavir/Ritonavir 4 1 3 0.635
  Oseltamivir 18 8 10 0.581
  Arbidol 10 6 4 0.151
  TCM 33 14 19 0.506
  Types of antivirus agents 2.11 ± 0.93 2.36 ± 0.75 1.95 ± 1.02 0.213
 Corticosteroids 12 8 4 0.031
 IVIG 9 4 5 1.000
 Antibiotics 22 10 12 0.392
 Anticoagulant 8 3 5 1.000
Virus shedding period (days) 22.09 ± 9.51 26.57 ± 10.35 19.10 ± 7.80 0.020
Swab testing times 3.81 ± 2.04 5.15 ± 2.38 2.89 ± 1.10 0.001
Consecutive swab testing negative times before discharging 3.03 ± 1.23 3.23 ± 1.42 2.89 ± 1.10 0.457
Swab testing interval (days) 6.10 ± 1.63 5.77 ± 1.36 6.34 ± 1.80 0.346
Outcomings
Discharged  32 12 20 0.551
Deceased 3 2 1  
  1. TCM traditional Chinese medicine, IVIG intravenous immune globulin, HCQ hydroxychloroquine, CQ chloroquine